A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Summary

This study will investigate how the body processes nasal glucagon (NG) and the effect of nasal glucagon on the body. The study is expected to last about 50 days for each participant. The study is open to adults with type 1 or type 2 diabetes and will last about 50 days.

Timeline

Start

2015-01

Primary completion

2015-04

Completion

2015-04

Drugs

Indications